J. Sligar
Triangle(US)Scynexis (United States)(US)
Publications by Year
Research Areas
Trypanosoma species research and implications, HIV/AIDS drug development and treatment, Signaling Pathways in Disease, Synthesis and Biological Evaluation, Research on Leishmaniasis Studies
Most-Cited Works
- → SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis(2011)296 cited
- → Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis(2010)102 cited
- → Benzoxaboroles: A New Class of Potential Drugs for Human African Trypanosomiasis(2011)87 cited
- Efficacy and Pharmacokinetics of SCYX-7158 (AN5568): a Novel and Potent Oxaborole-6-Carboxamide Selected as a Pre-Clinical Candidate for Once-Daily Oral Treatment for Stage 2 Human African Trypanosomiasis.(2009)
- SCYX 7158: chemistry background and new findings.(2010)
- Lead Optimization of Novel Boron-Containing Drug Candidates for the Treatment of Human African Trypanosomiasis.(2009)
- In Vitro Pharmacodynamics and Mechanism of Action Studies of Oxaborole 6-Carboxamides: A New Class of Compounds for the Treatment of African Trypanosomiasis.(2009)